July 12, 2018
Mathys and Squire Partner, Craig Titmus, and Technical Assistant, Lionel Newton, attended “ON Helix” Translational Research Conference, hosted by One Nucleus at the Babraham Research Campus in Cambridge.
A leading event for the Life Sciences industry, the conference provides a platform for discussion and discovery, exploring the path from early stage innovation to the clinic.
With talks ranging from alternative funding, due diligence and licensing plans, through to relationship management and NHS partnership case studies, this event covered the full lifecycle of clinical innovation and highlighted the strategic advantages of collaboration over competition.
Mathys & Squire has worked closely with One Nucleus over a number of years and we are delighted to be One Nucleus’ preferred provider of Intellectual Property advice.
For any questions or queries relating to biotech, life sciences and IP strategy, please contact Craig Titmus via [email protected]
Craig’s practice covers diverse biotechnological subject-matter, with a particular focus on vaccines, diagnostics, therapeutic antibodies and peptide conjugates and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including start-ups, SMEs, universities, large corporations and the UK Government.
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest: